Study confirms face masks’ effectiveness in reducing disease transmission, calls for improved public understanding

FHS
May 24, 2024
2:27 am

Researchers reviewed the benefits, practicalities, and harms of masks and masking, finding that masks are effective in reducing respiratory disease transmission despite some adverse effects, and emphasized the need for improved public understanding and policies.

Risk Adjusted Net Present Value: What is the current valuation of Aslan Pharmaceuticals’s Eblasakimab

The revenue for Eblasakimab is expected to reach an annual total of $430 mn by 2038 in the US based off GlobalDatas Expiry Model. The

September 8, 2024

Terns scores FDA orphan designation for CML therapy

Share this article TERN-701 is an oral allosteric BCR-ABL tyrosine kinase inhibitor (TKI). Image Credit: crystal light / Shutterstock. The US Food and Drug Administration

March 12, 2024

A fraught question for the children of Alzheimer’s: Is it coming for us?

My sister has a fantasy about our old age: She imagines that the seven siblings in our family will be living together again, in a

October 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.